Benjamin Knier1, Gildas Leppenetier2, Carmen Wetzlmair2, Lilian Aly1, Muna-Miriam Hoshi2, Verena Pernpeintner2, Viola Biberacher2, Achim Berthele2, Mark Mühlau3, Claus Zimmer4, Bernhard Hemmer5, Thomas Korn6. 1. Department of Neurology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany2Department of Experimental Neuroimmunology, Technische Universität München, Munich, Germany. 2. Department of Neurology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany. 3. Department of Neurology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany3Neuroimaging Center, Technische Universität München, Munich, Germany. 4. Department of Neuroradiology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany. 5. Department of Neurology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany5Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. 6. Department of Neurology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany2Department of Experimental Neuroimmunology, Technische Universität München, Munich, Germany5Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Abstract
Importance: Biomarkers to estimate long-term outcomes in patients with multiple sclerosis (MS) and to assign patients to individual treatment regimens are urgently needed. Objective: To assess whether retinal layer volumes are correlated with immune cell subsets and immunoglobulin indices in the cerebrospinal fluid and whether retinal layer volumes alone or in combination with intrathecal variables are associated with worsening of disease in patients with relapsing-remitting MS. Design, Setting, and Participants: This observational cohort study included 312 patients with relapsing-remitting MS in 2 independent cohorts (72 patients with short disease duration [cohort 1] and 240 patients with longer disease duration [cohort 2]) treated at a single German university hospital from April 15, 2013, through November 11, 2015. Main Outcomes and Measures: The common ganglion cell and inner plexiform layer (GCIPL) and inner nuclear layer (INL) volumes were tested for association with the immunoglobulin indices and the frequencies of immune cells in the cerebrospinal fluid (including B cells, T cells, and natural killer cells) (cohort 1). Volumes of GCIPL alone (cohorts 1 and 2) or GCIPL corrected for intrathecal B-cell frequencies (cohort 1) were tested for their association with worsening disability. Results: A total of 312 patients (212 women [67.9%] and 100 men [32.1%]; median age, 34.0 years [interquartile range (IQR), 28.0-42.0 years]) were available for analysis. In cohort 1 (50 women [69.4%] and 22 men [30.6%]; median age, 31.0 years [IQR, 26.3-38.3 years]), with short disease durations (median, 1.0 months [IQR, 1.0-2.0 months]), low GCIPL volumes were associated with increased intrathecal B-cell frequencies (median, 1.96% [IQR, 1.45%-4.20%]) and intrathecal IgG synthesis (median cerebrospinal fluid/serum IgG index, 0.78 [IQR, 0.53-1.07]). The INL volumes correlated with the frequencies of intrathecal CD56bright natural killer cells (r = 0.28; P = .007). Individuals with low GCIPL volumes (<1.99 mm3) had a 6.4-fold risk for worsening disability during follow-up compared with patients with higher GCIPL values (95% CI, 1.7-24.2; P = .007). This finding was reproduced in cohort 2 (162 women [67.5%] and 78 men [32.5%]; median age, 34.0 years [IQR, 29.0-42.0 years]) consisting of patients with longer disease durations (median, 36.0 months [IQR, 21.0-60.0 months]) (hazard ratio, 2.4; 95% CI, 1.2-4.8; P = .02). In both cohorts, INL volumes correlated with the prospective increase in T2 lesion load and the number of gadolinium-enhancing lesions. Conclusions and Relevance: Retinal layers reflect different aspects of disease activity during MS. Loss of GCIPL is associated with intrathecal B-cell immunity and constitutes an independent risk factor for worsening disability, whereas high INL volumes are associated with activity on magnetic resonance imaging in the brain parenchyma. Thus, retinal optical coherence tomography might be a means to support stratification of patients with MS for different therapeutic regimens.
Importance: Biomarkers to estimate long-term outcomes in patients with multiple sclerosis (MS) and to assign patients to individual treatment regimens are urgently needed. Objective: To assess whether retinal layer volumes are correlated with immune cell subsets and immunoglobulin indices in the cerebrospinal fluid and whether retinal layer volumes alone or in combination with intrathecal variables are associated with worsening of disease in patients with relapsing-remitting MS. Design, Setting, and Participants: This observational cohort study included 312 patients with relapsing-remitting MS in 2 independent cohorts (72 patients with short disease duration [cohort 1] and 240 patients with longer disease duration [cohort 2]) treated at a single German university hospital from April 15, 2013, through November 11, 2015. Main Outcomes and Measures: The common ganglion cell and inner plexiform layer (GCIPL) and inner nuclear layer (INL) volumes were tested for association with the immunoglobulin indices and the frequencies of immune cells in the cerebrospinal fluid (including B cells, T cells, and natural killer cells) (cohort 1). Volumes of GCIPL alone (cohorts 1 and 2) or GCIPL corrected for intrathecal B-cell frequencies (cohort 1) were tested for their association with worsening disability. Results: A total of 312 patients (212 women [67.9%] and 100 men [32.1%]; median age, 34.0 years [interquartile range (IQR), 28.0-42.0 years]) were available for analysis. In cohort 1 (50 women [69.4%] and 22 men [30.6%]; median age, 31.0 years [IQR, 26.3-38.3 years]), with short disease durations (median, 1.0 months [IQR, 1.0-2.0 months]), low GCIPL volumes were associated with increased intrathecal B-cell frequencies (median, 1.96% [IQR, 1.45%-4.20%]) and intrathecal IgG synthesis (median cerebrospinal fluid/serum IgG index, 0.78 [IQR, 0.53-1.07]). The INL volumes correlated with the frequencies of intrathecal CD56bright natural killer cells (r = 0.28; P = .007). Individuals with low GCIPL volumes (<1.99 mm3) had a 6.4-fold risk for worsening disability during follow-up compared with patients with higher GCIPL values (95% CI, 1.7-24.2; P = .007). This finding was reproduced in cohort 2 (162 women [67.5%] and 78 men [32.5%]; median age, 34.0 years [IQR, 29.0-42.0 years]) consisting of patients with longer disease durations (median, 36.0 months [IQR, 21.0-60.0 months]) (hazard ratio, 2.4; 95% CI, 1.2-4.8; P = .02). In both cohorts, INL volumes correlated with the prospective increase in T2 lesion load and the number of gadolinium-enhancing lesions. Conclusions and Relevance: Retinal layers reflect different aspects of disease activity during MS. Loss of GCIPL is associated with intrathecal B-cell immunity and constitutes an independent risk factor for worsening disability, whereas high INL volumes are associated with activity on magnetic resonance imaging in the brain parenchyma. Thus, retinal optical coherence tomography might be a means to support stratification of patients with MS for different therapeutic regimens.
Authors: Michaela A Seigo; Elias S Sotirchos; Scott Newsome; Aleksandra Babiarz; Christopher Eckstein; E'tona Ford; Jonathan D Oakley; Stephanie B Syc; Teresa C Frohman; John N Ratchford; Laura J Balcer; Elliot M Frohman; Peter A Calabresi; Shiv Saidha Journal: J Neurol Date: 2012-03-15 Impact factor: 4.849
Authors: Roberta Magliozzi; Owain W Howell; Cheryl Reeves; Federico Roncaroli; Richard Nicholas; Barbara Serafini; Francesca Aloisi; Richard Reynolds Journal: Ann Neurol Date: 2010-10 Impact factor: 10.422
Authors: Viola Biberacher; Paul Schmidt; Anisha Keshavan; Christine C Boucard; Ruthger Righart; Philipp Sämann; Christine Preibisch; Daniel Fröbel; Lilian Aly; Bernhard Hemmer; Claus Zimmer; Roland G Henry; Mark Mühlau Journal: Neuroimage Date: 2016-07-16 Impact factor: 6.556
Authors: W J Brownlee; D R Altmann; P Alves Da Mota; J K Swanton; K A Miszkiel; Cam Gandini Wheeler-Kingshott; O Ciccarelli; D H Miller Journal: Mult Scler Date: 2016-08-06 Impact factor: 6.312
Authors: S Cepok; M Jacobsen; S Schock; B Omer; S Jaekel; I Böddeker; W H Oertel; N Sommer; B Hemmer Journal: Brain Date: 2001-11 Impact factor: 13.501
Authors: Shiv Saidha; Elias S Sotirchos; Mohamed A Ibrahim; Ciprian M Crainiceanu; Jeffrey M Gelfand; Yasir J Sepah; John N Ratchford; Jiwon Oh; Michaela A Seigo; Scott D Newsome; Laura J Balcer; Elliot M Frohman; Ari J Green; Quan D Nguyen; Peter A Calabresi Journal: Lancet Neurol Date: 2012-10-04 Impact factor: 44.182
Authors: Xavier Montalban; Giancarlo Comi; Jack Antel; Paul O'Connor; Ana de Vera; Malika Cremer; Nikolaos Sfikas; Philipp von Rosenstiel; Ludwig Kappos Journal: J Neurol Date: 2015-09-04 Impact factor: 4.849
Authors: John N Ratchford; Shiv Saidha; Elias S Sotirchos; Jiwon A Oh; Michaela A Seigo; Christopher Eckstein; Mary K Durbin; Jonathan D Oakley; Scott A Meyer; Amy Conger; Teresa C Frohman; Scott D Newsome; Laura J Balcer; Elliot M Frohman; Peter A Calabresi Journal: Neurology Date: 2013-01-01 Impact factor: 9.910
Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: Jeffrey Lambe; Kathryn C Fitzgerald; Olwen C Murphy; Angeliki G Filippatou; Elias S Sotirchos; Grigorios Kalaitzidis; Elena Vasileiou; Nicole Pellegrini; Esther Ogbuokiri; Brandon Toliver; Nicholas J Luciano; Simidele Davis; Nicholas Fioravante; Ohemaa Kwakyi; Hunter Risher; Ciprian M Crainiceanu; Jerry L Prince; Scott D Newsome; Ellen M Mowry; Shiv Saidha; Peter A Calabresi Journal: Neurology Date: 2021-03-02 Impact factor: 9.910
Authors: Natascha Schurz; Lydia Sariaslani; Patrick Altmann; Fritz Leutmezer; Christoph Mitsch; Berthold Pemp; Paulus Rommer; Tobias Zrzavy; Thomas Berger; Gabriel Bsteh Journal: Eye Brain Date: 2021-03-12
Authors: Lilian Aly; Christina Noll; Rebecca Wicklein; Elisabeth Wolf; Eva Feodora Romahn; Josphine Wauschkuhn; Sami Hosari; Christian Mardin; Achim Berthele; Bernhard Hemmer; Thomas Korn; Benjamin Knier Journal: Neurol Neuroimmunol Neuroinflamm Date: 2022-03-17